trending Market Intelligence /marketintelligence/en/news-insights/trending/krqv_mdnxnur-oac2frm_q2 content esgSubNav
In This List

Lilly's animal health unit prices $2B debt offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Lilly's animal health unit prices $2B debt offering

Eli Lilly and Co.'s Elanco Animal Health Inc. unit is looking to raise $2 billion in a debt offering.

Elanco, which recently filed for an IPO, is offering $500 million worth of 3.912% senior notes due Aug. 27, 2021; $750 million worth of 4.272% senior notes due Aug. 28, 2023; and $750 million worth of 4.90% senior notes due Aug. 28, 2028.

The transaction is expected to close Aug. 28, subject to customary closing conditions.

Earlier this year, Lilly said it was spinning off its animal health unit via an IPO following a strategic review of the business that started in late 2017.

The Indianapolis-based maker of diabetes medicines said it will focus on its pharmaceutical business instead.